{"DataElement":{"publicId":"2603678","version":"1","preferredName":"Laboratory Procedure Within Clinical Study Protocol Upper Limit of Normal Total Bilirubin Measurement Ind-2","preferredDefinition":"the yes/no indicator related to the top value of the range for total bilirubin falling within parameters set forth by the guidelines for a clinical trial.","longName":"LAB_W_PR_UL_TBM_IND","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2603677","version":"1","preferredName":"Laboratory Procedure Within Clinical Study Protocol Upper Limit of Normal Total Bilirubin Measurement","preferredDefinition":"information related to the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for total bilirubin, bilirubin is a breakdown product of hemoglobin and total bilirubin is measured to screen for or to monitor liver or gall bladder dysfunction, falling within parameters set forth by the action plan and guidelines for a clinical trial.","longName":"LAB_W_PRO_ULN_TTLBIL","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2780801","version":"1","preferredName":"Within Clinical Study Protocol Upper Limit of Normal Total Bilirubin Measurement","preferredDefinition":"On the inside; contained in.:An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:Bilirubin is a breakdown product of hemoglobin. Total and direct bilirubin are usually measured to screen for or to monitor liver or gall bladder dysfunction. (from MedlinePlus Medical Encyclopedia)","longName":"C25282:C25320:C25706:C38037","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Total Bilirubin Measurement","conceptCode":"C38037","definition":"The measurement of the total amount of bilirubin present in a particular substrate. The substrate most often tested is blood, but other fluids extracted from the body may be used periodically depending on the purpose of the test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5665CCC0-A68F-4535-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-09-08","modifiedBy":"ONEDATA","dateModified":"2008-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7B03CB-45F0-3315-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]}],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"LAB_W_PR_UL_TBM_IND","type":"USED_BY","context":"CITN"}],"ReferenceDocuments":[{"name":"Total bilirubin <= 1.5 x ULN","type":"Preferred Question Text","description":"Total bilirubin <= 1.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Total bilirubin <= 2.0 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Total bilirubin <= ULN unless the patient has a grade 1 bilirubin elevation (> ULN to 1.5 x ULN) resulting from Gilbert's disease or similar syndrome due to slow conjugation of bilirubin","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Total bilirubin <=1.5 x upper limit of normal (ULN) ","url":null,"context":"CTEP"},{"name":"CRF Text6","type":"Alternate Question Text","description":"Total bilirubin <=1.5 x Institutional Upper Limit of Normal (ULN) unless due to Gilbert's disease.  If total bilirubin is >1.5 x ULN, a direct bilirubin should be performed and must be <1.5 mg/dL for Gilbert's disease to be diagnosed","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Total bilirubin <=1.5 x ULN, or if total bilirubin is >1.5 ULN, the direct bilirubin must be normal","url":null,"context":"CTEP"},{"name":"CRF Text7","type":"Alternate Question Text","description":"Total bilirubin =< upper limit of normal (ULN) ","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Total bilirubin <= 1.5 x institutional limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CRF Text8","type":"Alternate Question Text","description":"Total bilirubin <= 1.5 x institutional upper limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CRF Text9","type":"Alternate Question Text","description":"Total bilirubin within normal institutional limits","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Total bilirubin <= 2.0 x institutional upper limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CRF Text 10","type":"Alternate Question Text","description":"Total bilirubin <1.5 x institutional upper limit of normal (Bilirubin <3 x institutional upper limit of normal for Gilbert's syndrome)","url":null,"context":"CTEP"},{"name":"CRF Text 11","type":"Alternate Question Text","description":"Total bilirubin within normal institutional limits <= 1.5 x institutional upper limit of normal","url":null,"context":"CTEP"},{"name":"CRF Text 12","type":"Alternate Question Text","description":"Total bilirubin within normal institutional limits < 1.5 x institutional upper limit of normal","url":null,"context":"CTEP"},{"name":"CRF Text 13","type":"Alternate Question Text","description":"Total bilirubin less than or equal to 1.5 x institutional ULN within 14 days prior to registration","url":null,"context":"NRG"},{"name":"Is pre-study serum bilirubin greater than 1.5 x upper limit of normal?","type":"Alternate Question Text","description":"Is pre-study serum bilirubin greater than 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"CRF Text 15","type":"Alternate Question Text","description":"Direct bilirubin <= ULN for patients with total bilirubin levels > 1.5 ULN","url":null,"context":"CTEP"},{"name":"CRF Text 14","type":"Alternate Question Text","description":"Direct bilirubin <= institutional ULN for patients with total bilirubin levels >1.5 x ULN","url":null,"context":"CTEP"},{"name":"CRF Text 16","type":"Alternate Question Text","description":"Bilirubin <1.5 x upper limit of normal (ULN)","url":null,"context":"CTEP"},{"name":"CITN","type":"Alternate Question Text","description":"Total bilirubin within normal institutional limits <1.5 x institutional upper limit of normal (Bilirubin <3 x institutional upper limit of normal for Gilbert's syndrome)","url":null,"context":"CITN"},{"name":"CITN Text","type":"Alternate Question Text","description":"Serum total bilirubin <= 1.5 x institutional ULN (Values post biliary stenting are allowed for eligibility).","url":null,"context":"CITN"},{"name":"CRF Text 17","type":"Alternate Question Text","description":"Is the patient's total bilirubin <= 1.5 x ULN (upper limit of normal) for the lab?","url":null,"context":"CTEP"},{"name":"CRF Text 18","type":"Alternate Question Text","description":"Is bilirubin <= 2.5 x ULN?","url":null,"context":"CTEP"},{"name":"CRF Text 19","type":"Alternate Question Text","description":"Is total serum bilirubin level <= 1.5 x ULN?","url":null,"context":"CTEP"},{"name":"CRF Text 20","type":"Alternate Question Text","description":"Is serum bilirubin <= 1.5 x ULN?","url":null,"context":"CTEP"},{"name":"CRF Text 21","type":"Alternate Question Text","description":"Is the patient's total bilirubin less than or equal to 1.5 x ULN for the lab or direct bilirubin less than or equal to ULN for patients with bilirubin levels greater than 1.5 x ULN within 14 days prior to randomization?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Is total serum bilirubin level lower than or equal to 1.5 x ULN? (Patient's with known Gilbert's disease who have bilirubin level lower than or equal to 3 x ULN may be enrolled)","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Is total serum bilirubin level lower than or equal to 1.5 x ULN?","url":null,"context":"NRG"},{"name":"CRF Text 22","type":"Alternate Question Text","description":"Is total serum bilirubin level less than or equal to 1.5 x ULN?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Is serum bilirubin less than or equal to 1.5 x ULN?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Is the patient's total bilirubin less than or equal to 1.5 x ULN for the lab or direct bilirubin less than or equal to ULN for patients with bilirubin levels greater than 1.5 x ULN, within 14 days prior to study entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_6","type":"Alternate Question Text","description":"Is total bilirubin level less than or equal to 1.5 x ULN within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_4","type":"Alternate Question Text","description":"Is total bilirubin less than or equal to ULN (upper limit of normal) for the lab within 28 days before study entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_7","type":"Alternate Question Text","description":"Is total serum bilirubin level less than or equal to 1.5 x ULN within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_5","type":"Alternate Question Text","description":"Is total bilirubin less than or equal to ULN (upper limit of normal) for the lab within 28 days before randomization?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Is total bilirubin level less than or equal to the institutional upper limit of normal within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Is total bilirubin level less than or equal to the institutional upper limit of normal (ULN) within 14 days prior to second registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 3","type":"Alternate Question Text","description":"Is the patient's total bilirubin less than or equal to 4 x ULN (upper limit of normal)?","url":null,"context":"NRG"},{"name":"NRG CRF Text 4","type":"Alternate Question Text","description":"Is total bilirubin level less than or equal to 1.5 x institutional upper limit of normal (ULN)?","url":null,"context":"NRG"},{"name":"NRG CRF Text 5","type":"Alternate Question Text","description":"Is total bilirubin less than or equal to ULN for the lab within 16 weeks prior to pre-entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_8","type":"Alternate Question Text","description":"Is total bilirubin less than or equal to ULN (upper limit of normal) for the lab within 28 days before Step 1/Study entry?","url":null,"context":"NRG"},{"name":"NRG CRF Text 6","type":"Alternate Question Text","description":"Is total bilirubin level less than or equal to the institutional upper limit of normal?","url":null,"context":"NRG"},{"name":"NRG CRF Text 7","type":"Alternate Question Text","description":"Is total bilirubin level less than or equal to the institutional upper limit of normal (ULN)?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7B0514-77DC-3279-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"TYRRELLM","dateModified":"2023-09-29","changeDescription":"Replaced VD Labs Ind-2  2181518v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"9.29.2023 Added AQT per request CADSR0002902 _mmt\r\n9.29.2023 Added AQT per request CADSR0002901_mmt\r\n9.28.2023 Added AQT per request CADSR0002895_mmt","unresolvedIssues":null,"deletedIndicator":"No"}}